Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 51 studies | 53% ± 19% | |
endothelial cell of lymphatic vessel | 18 studies | 33% ± 13% | |
capillary endothelial cell | 17 studies | 57% ± 12% | |
vein endothelial cell | 14 studies | 57% ± 17% | |
endothelial cell of vascular tree | 14 studies | 59% ± 16% | |
endothelial cell of artery | 12 studies | 43% ± 19% | |
pericyte | 6 studies | 39% ± 20% | |
fibroblast | 5 studies | 23% ± 9% | |
glomerular endothelial cell | 4 studies | 99% ± 1% | |
endocardial cell | 3 studies | 79% ± 2% | |
endothelial cell of sinusoid | 3 studies | 43% ± 31% |
Insufficient scRNA-seq data for expression of EMCN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 5127.73 | 653 / 653 | 93% | 19.29 | 561 / 605 |
prostate | 98% | 1595.04 | 241 / 245 | 93% | 10.00 | 468 / 502 |
breast | 100% | 4397.88 | 458 / 459 | 92% | 11.76 | 1026 / 1118 |
adrenal gland | 99% | 1857.73 | 255 / 258 | 86% | 12.52 | 197 / 230 |
kidney | 100% | 6372.79 | 89 / 89 | 80% | 31.96 | 717 / 901 |
lung | 100% | 4155.14 | 577 / 578 | 66% | 5.90 | 765 / 1155 |
esophagus | 85% | 1158.87 | 1227 / 1445 | 64% | 5.12 | 117 / 183 |
bladder | 95% | 1611.38 | 20 / 21 | 50% | 3.80 | 253 / 504 |
uterus | 99% | 2570.87 | 169 / 170 | 39% | 3.15 | 179 / 459 |
stomach | 68% | 650.64 | 245 / 359 | 65% | 5.43 | 187 / 286 |
brain | 44% | 320.52 | 1172 / 2642 | 89% | 6.38 | 629 / 705 |
intestine | 80% | 983.41 | 770 / 966 | 50% | 3.31 | 263 / 527 |
skin | 58% | 597.60 | 1057 / 1809 | 54% | 7.57 | 256 / 472 |
adipose | 100% | 4575.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
heart | 100% | 2188.41 | 857 / 861 | 0% | 0 | 0 / 0 |
ovary | 73% | 723.43 | 132 / 180 | 26% | 1.34 | 110 / 430 |
pancreas | 13% | 82.70 | 42 / 328 | 80% | 7.65 | 143 / 178 |
eye | 0% | 0 | 0 / 0 | 85% | 45.87 | 68 / 80 |
muscle | 80% | 683.69 | 640 / 803 | 0% | 0 | 0 / 0 |
liver | 6% | 30.38 | 13 / 226 | 67% | 4.74 | 273 / 406 |
blood vessel | 71% | 1009.74 | 947 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 31% | 1.49 | 14 / 45 |
spleen | 14% | 99.93 | 34 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.65 | 4 / 29 |
peripheral blood | 0% | 0.68 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0061484 | Biological process | hematopoietic stem cell homeostasis |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
Gene name | EMCN |
Protein name | Endomucin, isoform CRA_a (cDNA, FLJ94060, Homo sapiens endomucin (EMCN), mRNA) Endomucin Endomucin (Endomucin-2) (Gastric cancer antigen Ga34) (Mucin-14) (MUC-14) |
Synonyms | MUC14 EMCN2 hCG_39439 |
Description | FUNCTION: Endothelial sialomucin, also called endomucin or mucin-like sialoglycoprotein, which interferes with the assembly of focal adhesion complexes and inhibits interaction between cells and the extracellular matrix. |
Accessions | D6RHW5 Q9ULC0 ENST00000305864.7 [Q9ULC0-2] H0YAA7 Q4W5J1 ENST00000506300.5 ENST00000296420.9 [Q9ULC0-1] ENST00000511970.5 [Q9ULC0-3] ENST00000502569.1 |